ArticleThoracic cancer2016

Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors combined with chemotherapy in first-line treatment in an advanced non-small cell lung cancer patient with EGFR sensitive mutation.

Aimi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.